Information about several papers discussed at the symposium on cellular therapy of cancer, held in Manchester, England from December 2-3, 2006, is presented. The participants discussed several issues related to gene-modified T cell-based immunotherapies. Those who took part in the discussion included medical experts Balbino Alarcon, Janos Szollosi and Zelig Eshhar.